Latest Corporate News


Montreal, July 2108 - Last July 8th and 9th, the Pharmascience team participated in the 10th edition of the Enbridge Ride to Conquer Cancer Challenge benefiting the Segal Cancer Center at the Jewish General Hospital and raised a toatal amount of $88,257.90.

The Ride to Conquer Cancer is a fundraising event during which participants bike from Montreal to Quebec City over the span of two-day, totaling 230 kilometers. The event has garnered a spirited success for many years and rallies an entire community in support of one single cause: to raise funds to advance cancer research. This year, 1,308 participants and their peers collectively raised $4.8 million in benefit to the Segal Cancer Centre at the Jewish General Hospital.

For many years now, Pharmascience has been a proud sponsor of the Ride to Conquer Cancer. Given Pharmascience’s continued dedication to helping advance cancer research, we are pleased to announce our intention to renew the experience in 2019 during the 11th edition of the Enbridge® Ride to Conquer Cancer.

Pharmascience has a strong commitment to cancer research, with the Goodman Cancer Research Center, a recognized world-class research center that contributes to innovative developments in the treatment and ultimately the cure for cancer.

We wish to recognize the participation of:

Stephane Charland, Kurt Koscher, Francis Gaudreau, Valerie Pilon, Francois Bujold, Jessica Masse, Alejandro Flores Maso, Diana Barrero, Richard Garon, Marie-Christine Leblond, Duc Thang Nguyen, Etienne Seguin Lawlor, Jean-Francois Lemieux, Eden Almakias, Yann de la Fouchardiere, Boris Gorbatyuk, Steven Nguyen, Manon Thibodeau, Alexandra Coulombe, Annick Stolk, Alexis Trépanier, Julie Laniel, Francoise Munger, Natalie Kakon, Sandra sauvageau, Lori Anders, Carlo De Luca, Anik Roy Trudel, Gilles Baron, Claudia Boisvert et Marc Nadeau.

About Pharmascience Inc.

Founded in 1983, Pharmascience Inc. is the largest pharmaceutical employer in Quebec with over 1,500 employees proudly headquartered in Montreal. Pharmascience Inc. is a full-service privately owned pharmaceutical company with strong roots in Canada and a growing global reach with product distribution in over 60 countries. Ranked 51st among Canada's top 100 Research & Development (R&D) investors with over $49 million invested in 2016, Pharmascience Inc. is the 3rd largest manufacturer of over-the-counter generic drugs in the country.

Pharmascience Inc. is a leading manufacturer and marketer of prescription generic, over-the-counter, and behind-the-counter products as well as FDA approved Canadian-made injectables. The company commercializes nearly 300 product families in 20 different dosage forms for over 2,000 products. In Canada alone, more than 45 million prescriptions a year are filled with Pharmascience products.

In 2018, the prestigious Forbes magazine ranked Pharmascience Inc. among its list of top 300 employers. Pharmascience Inc. has strong long-standing philanthropic ties with its communities, both locally and internationally. For more than 20 years, Pharmascience has been working through Health Partners International of Canada (HPIC) as a partner of choice to increase access to medicine. Pharmascience's total donations of essential medicine is close to $70 million.

Back to News